Details

Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop
ID Barnard-Kelly, Katharine (Author), ID Battelino, Tadej (Author), ID Schnell, Oliver (Author), et al.

.pdfPDF - Presentation file, Download (2,41 MB)
MD5: 29C203485AC1088553A3A3E022A509A9
URLURL - Source URL, Visit https://link.springer.com/article/10.1186/s12933-024-02550-2 This link opens in a new window

Abstract
Recent clinical practice guidelines for diabetes, obesity, cardiovascular disease (CVD) and chronic kidney disease (CKD) emphasise a holistic, person-centred approach to care. However, they do not include recommendations for the assessment of patient-reported outcomes (PROs), which would – dependent on the topic of guideline – be important for improving shared decision-making, patients’ concordance with guideline recommendations, clinical outcomes and health-related quality of life (HRQoL). The Taskforce of the Guideline Workshop discussed PROs in diabetes, obesity, CVD and CKD as well as the relevance of their inclusion in clinical practice guidelines for the management of these conditions.

Language:English
Keywords:cardiovascular disease, chronic kidney disease, diabetes, obesity, person-reported outcomes
Work type:Article
Typology:1.03 - Other scientific articles
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:12 str.
Numbering:Vol. 24, iss. 1, art. 68
PID:20.500.12556/RUL-182766 This link opens in a new window
UDC:616
ISSN on article:1475-2840
DOI:10.1186/s12933-024-02550-2 This link opens in a new window
COBISS.SI-ID:251144707 This link opens in a new window
Publication date in RUL:22.05.2026
Views:258
Downloads:181
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Cardiovascular diabetology
Shortened title:Cardiovasc Diabetol
Publisher:Springer Nature
ISSN:1475-2840
COBISS.SI-ID:2595092 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Projects

Funder:AstraZeneca Pharmaceuticals LP

Funder:Bayer AG

Funder:Boehringer Ingelheim International GmbH

Funder:Dexcom, Inc.

Funder:Eli Lilly and Company

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back